# Edenor: financial statements, quarterly

EDN · NYSE · CIK 1395213 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/edn.md) · [Financials](/companies/edn/financials.md) · [Filings](/companies/edn/filings.md) · [Insiders](/companies/edn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/edn/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2014-12-31) | period not labelled (2015-12-31) | period not labelled (2016-12-31) | FY2017 (2017-12-31) | FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.2](/filings/0001292814-18-001826.md) | [0.1](/filings/0001292814-18-001826.md) | [0.3](/filings/0001292814-18-001826.md) | [(0.4)](/filings/0001292814-19-001619.md) | [0.0](/filings/0001292814-20-001461.md) | [0.6](/filings/0001292814-21-001740.md) | [6.6](/filings/0001292814-22-001393.md) | [6.2](/filings/0001292814-23-001639.md) | [11.1](/filings/0001292814-25-001581.md) | [19.9](/filings/0001292814-25-001581.md) | [23.9](/filings/0001292814-25-001581.md) |
| Current assets | $bn | not reported | not reported | [6.6](/filings/0001292814-18-001826.md) | [13.7](/filings/0001292814-19-001619.md) | [21.1](/filings/0001292814-20-001461.md) | [24.3](/filings/0001292814-21-001740.md) | [35.2](/filings/0001292814-22-001393.md) | [81.8](/filings/0001292814-23-001639.md) | [566](/filings/0001292814-25-001581.md) | [506](/filings/0001292814-25-001581.md) | [966](/filings/0001292814-25-001581.md) |
| Total assets | $bn | not reported | not reported | [18.9](/filings/0001292814-18-001826.md) | [70.9](/filings/0001292814-19-001619.md) | [118](/filings/0001292814-20-001461.md) | [163](/filings/0001292814-21-001740.md) | [225](/filings/0001292814-22-001393.md) | [463](/filings/0001292814-23-001639.md) | [3,256](/filings/0001292814-25-001581.md) | [3,286](/filings/0001292814-25-001581.md) | [3,980](/filings/0001292814-25-001581.md) |
| Current liabilities | $bn | not reported | not reported | [9.6](/filings/0001292814-18-001826.md) | [18.5](/filings/0001292814-19-001619.md) | [32.3](/filings/0001292814-20-001461.md) | [33.5](/filings/0001292814-21-001740.md) | [63.6](/filings/0001292814-22-001393.md) | [190](/filings/0001292814-23-001639.md) | [1,348](/filings/0001292814-25-001581.md) | [775](/filings/0001292814-25-001581.md) | [1,090](/filings/0001292814-25-001581.md) |
| Total liabilities | $bn | not reported | not reported | [18.6](/filings/0001292814-18-001826.md) | [43.1](/filings/0001292814-19-001619.md) | [70.8](/filings/0001292814-20-001461.md) | [82.1](/filings/0001292814-21-001740.md) | [130](/filings/0001292814-22-001393.md) | [320](/filings/0001292814-23-001639.md) | [2,213](/filings/0001292814-25-001581.md) | [2,053](/filings/0001292814-25-001581.md) | [2,473](/filings/0001292814-25-001581.md) |
| Shareholders' equity | $bn | [0.4](/filings/0001292814-18-001826.md) | [22.4](/filings/0001292814-19-001619.md) | [34.9](/filings/0001292814-20-001461.md) | [58.2](/filings/0001292814-21-001740.md) | [97.8](/filings/0001292814-22-001393.md) | [237](/filings/0001292814-23-001639.md) | [576](/filings/0001292814-24-001535.md) | [1,090](/filings/0001292814-25-001581.md) | [1,043](/filings/0001292814-25-001581.md) | [1,233](/filings/0001292814-25-001581.md) | [1,507](/filings/0001292814-25-001581.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity

Shares outstanding: 906,455,100 at 2021-12-31, from the cover of the [20-F filed 2022-04-05](/filings/0001292814-22-001393.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. No prices; not investment advice.